Advertisement

Topics

Thrombotic Microangiopathy Associated with Oxymorphone Abuse

19:00 EST 29 Nov 2016 | NEJM

TMA was induced by repeated intravenous doses of high-molecular-weight polyethylene oxide, an ingredient of reformulated extended-release oxymorphone.

Original Article: Thrombotic Microangiopathy Associated with Oxymorphone Abuse

NEXT ARTICLE

More From BioPortfolio on "Thrombotic Microangiopathy Associated with Oxymorphone Abuse"

Quick Search
Advertisement